nodes	percent_of_prediction	percent_of_DWPC	metapath
Levosimendan—TNNC1—dilated cardiomyopathy	0.817	1	CbGaD
Levosimendan—KCNJ8—ATP sensitive Potassium channels—ABCC9—dilated cardiomyopathy	0.0147	0.1	CbGpPWpGaD
Levosimendan—KCNJ11—ATP sensitive Potassium channels—ABCC9—dilated cardiomyopathy	0.00694	0.0476	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—TCAP—dilated cardiomyopathy	0.00638	0.0437	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—MYBPC3—dilated cardiomyopathy	0.00638	0.0437	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—TCAP—dilated cardiomyopathy	0.00542	0.0372	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—MYBPC3—dilated cardiomyopathy	0.00542	0.0372	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—MYH6—dilated cardiomyopathy	0.00483	0.0331	CbGpPWpGaD
Levosimendan—TNNC1—cardiac ventricle—dilated cardiomyopathy	0.00433	0.128	CbGeAlD
Levosimendan—TNNC1—Striated Muscle Contraction—TNNI3—dilated cardiomyopathy	0.00431	0.0295	CbGpPWpGaD
Levosimendan—TNNC1—Muscle contraction—TCAP—dilated cardiomyopathy	0.00428	0.0294	CbGpPWpGaD
Levosimendan—TNNC1—Muscle contraction—MYBPC3—dilated cardiomyopathy	0.00428	0.0294	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—MYH6—dilated cardiomyopathy	0.00411	0.0282	CbGpPWpGaD
Levosimendan—TNNC1—myocardium—dilated cardiomyopathy	0.00407	0.12	CbGeAlD
Levosimendan—TNNC1—Striated Muscle Contraction—DES—dilated cardiomyopathy	0.00394	0.027	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—TPM1—dilated cardiomyopathy	0.00366	0.0251	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—TNNT2—dilated cardiomyopathy	0.00366	0.0251	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—TNNI3—dilated cardiomyopathy	0.00366	0.0251	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—TTN—dilated cardiomyopathy	0.00344	0.0236	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—DES—dilated cardiomyopathy	0.00335	0.023	CbGpPWpGaD
Levosimendan—KCNJ8—cardiac ventricle—dilated cardiomyopathy	0.00325	0.0959	CbGeAlD
Levosimendan—TNNC1—Muscle contraction—MYH6—dilated cardiomyopathy	0.00325	0.0223	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—TPM1—dilated cardiomyopathy	0.00311	0.0213	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—TNNT2—dilated cardiomyopathy	0.00311	0.0213	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—ACTC1—dilated cardiomyopathy	0.00311	0.0213	CbGpPWpGaD
Levosimendan—KCNJ8—myocardium—dilated cardiomyopathy	0.00306	0.0902	CbGeAlD
Levosimendan—TNNC1—Striated Muscle Contraction—ACTN2—dilated cardiomyopathy	0.00299	0.0205	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—TTN—dilated cardiomyopathy	0.00293	0.0201	CbGpPWpGaD
Levosimendan—TNNC1—Muscle contraction—TNNI3—dilated cardiomyopathy	0.00289	0.0198	CbGpPWpGaD
Levosimendan—KCNJ8—Inwardly rectifying K+ channels—ABCC9—dilated cardiomyopathy	0.00285	0.0195	CbGpPWpGaD
Levosimendan—TNNC1—heart—dilated cardiomyopathy	0.00284	0.0839	CbGeAlD
Levosimendan—TNNC1—Muscle contraction—DES—dilated cardiomyopathy	0.00265	0.0181	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—DMD—dilated cardiomyopathy	0.00261	0.0179	CbGpPWpGaD
Levosimendan—PDE3A—cardiac ventricle—dilated cardiomyopathy	0.00259	0.0766	CbGeAlD
Levosimendan—TNNC1—Striated Muscle Contraction—ACTN2—dilated cardiomyopathy	0.00254	0.0174	CbGpPWpGaD
Levosimendan—TNNC1—Muscle contraction—TNNT2—dilated cardiomyopathy	0.00246	0.0169	CbGpPWpGaD
Levosimendan—TNNC1—Muscle contraction—TPM1—dilated cardiomyopathy	0.00246	0.0169	CbGpPWpGaD
Levosimendan—PDE3A—myocardium—dilated cardiomyopathy	0.00244	0.072	CbGeAlD
Levosimendan—TNNC1—cardiac atrium—dilated cardiomyopathy	0.00243	0.0718	CbGeAlD
Levosimendan—TNNC1—Muscle contraction—TTN—dilated cardiomyopathy	0.00231	0.0159	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—DMD—dilated cardiomyopathy	0.00222	0.0152	CbGpPWpGaD
Levosimendan—KCNJ8—heart—dilated cardiomyopathy	0.00213	0.063	CbGeAlD
Levosimendan—TNNC1—Muscle contraction—ACTN2—dilated cardiomyopathy	0.00201	0.0137	CbGpPWpGaD
Levosimendan—KCNJ8—cardiac atrium—dilated cardiomyopathy	0.00182	0.0539	CbGeAlD
Levosimendan—TNNC1—Muscle contraction—DMD—dilated cardiomyopathy	0.00175	0.012	CbGpPWpGaD
Levosimendan—KCNJ11—heart—dilated cardiomyopathy	0.00174	0.0513	CbGeAlD
Levosimendan—TNNC1—Muscle contraction—VCL—dilated cardiomyopathy	0.00171	0.0117	CbGpPWpGaD
Levosimendan—PDE3A—heart—dilated cardiomyopathy	0.0017	0.0503	CbGeAlD
Levosimendan—PDE3A—cardiac atrium—dilated cardiomyopathy	0.00146	0.043	CbGeAlD
Levosimendan—KCNJ11—Inwardly rectifying K+ channels—ABCC9—dilated cardiomyopathy	0.00135	0.00925	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00121	0.00832	CbGpPWpGaD
Levosimendan—KCNJ8—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00113	0.00771	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000865	0.00593	CbGpPWpGaD
Levosimendan—KCNJ11—Potassium Channels—ABCC9—dilated cardiomyopathy	0.000533	0.00365	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—ABCC9—dilated cardiomyopathy	0.000491	0.00337	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—ACTN2—dilated cardiomyopathy	0.000471	0.00323	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000338	0.00231	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000293	0.00201	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.000262	0.0018	CbGpPWpGaD
Levosimendan—KCNJ11—Type II diabetes mellitus—TNF—dilated cardiomyopathy	0.000253	0.00173	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—ABCC9—dilated cardiomyopathy	0.000233	0.00159	CbGpPWpGaD
Levosimendan—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.000227	0.0762	CcSEcCtD
Levosimendan—KCNJ11—Neuronal System—ACTN2—dilated cardiomyopathy	0.000223	0.00153	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.000213	0.00146	CbGpPWpGaD
Levosimendan—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.000193	0.0646	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—TTN—dilated cardiomyopathy	0.00018	0.00123	CbGpPWpGaD
Levosimendan—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.000174	0.0583	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—ACTN2—dilated cardiomyopathy	0.000156	0.00107	CbGpPWpGaD
Levosimendan—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000153	0.0514	CcSEcCtD
Levosimendan—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.000133	0.0447	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—VCL—dilated cardiomyopathy	0.000133	0.00091	CbGpPWpGaD
Levosimendan—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000131	0.044	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000111	0.000764	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—RAF1—dilated cardiomyopathy	0.000107	0.000735	CbGpPWpGaD
Levosimendan—Angiopathy—Furosemide—dilated cardiomyopathy	0.000106	0.0354	CcSEcCtD
Levosimendan—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000104	0.0349	CcSEcCtD
Levosimendan—Malnutrition—Furosemide—dilated cardiomyopathy	0.000101	0.034	CcSEcCtD
Levosimendan—Dizziness—Spironolactone—dilated cardiomyopathy	0.000101	0.0337	CcSEcCtD
Levosimendan—Vomiting—Spironolactone—dilated cardiomyopathy	9.67e-05	0.0324	CcSEcCtD
Levosimendan—Headache—Spironolactone—dilated cardiomyopathy	9.53e-05	0.0319	CcSEcCtD
Levosimendan—KCNJ11—Metabolism—ANKRD1—dilated cardiomyopathy	9.09e-05	0.000623	CbGpPWpGaD
Levosimendan—Nausea—Spironolactone—dilated cardiomyopathy	9.04e-05	0.0303	CcSEcCtD
Levosimendan—KCNJ11—Metabolism—TAZ—dilated cardiomyopathy	8.55e-05	0.000586	CbGpPWpGaD
Levosimendan—Nervous system disorder—Furosemide—dilated cardiomyopathy	8.12e-05	0.0272	CcSEcCtD
Levosimendan—Angiopathy—Lisinopril—dilated cardiomyopathy	7.93e-05	0.0266	CcSEcCtD
Levosimendan—Hypotension—Furosemide—dilated cardiomyopathy	7.74e-05	0.0259	CcSEcCtD
Levosimendan—KCNJ11—Metabolism—SDHA—dilated cardiomyopathy	7.73e-05	0.00053	CbGpPWpGaD
Levosimendan—Mental disorder—Lisinopril—dilated cardiomyopathy	7.66e-05	0.0257	CcSEcCtD
Levosimendan—Malnutrition—Lisinopril—dilated cardiomyopathy	7.61e-05	0.0255	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	7.15e-05	0.0239	CcSEcCtD
Levosimendan—Constipation—Furosemide—dilated cardiomyopathy	7.08e-05	0.0237	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—ITGB1—dilated cardiomyopathy	6.67e-05	0.000457	CbGpPWpGaD
Levosimendan—Tachycardia—Lisinopril—dilated cardiomyopathy	6.06e-05	0.0203	CcSEcCtD
Levosimendan—PDE3A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	5.98e-05	0.00041	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	5.98e-05	0.00041	CbGpPWpGaD
Levosimendan—Hypotension—Lisinopril—dilated cardiomyopathy	5.8e-05	0.0194	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—CD36—dilated cardiomyopathy	5.69e-05	0.00039	CbGpPWpGaD
Levosimendan—Diarrhoea—Furosemide—dilated cardiomyopathy	5.66e-05	0.019	CcSEcCtD
Levosimendan—Insomnia—Lisinopril—dilated cardiomyopathy	5.62e-05	0.0188	CcSEcCtD
Levosimendan—PDE3A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	5.56e-05	0.000381	CbGpPWpGaD
Levosimendan—Dizziness—Furosemide—dilated cardiomyopathy	5.47e-05	0.0183	CcSEcCtD
Levosimendan—PDE3A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	5.43e-05	0.000372	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	5.43e-05	0.000372	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	5.38e-05	0.000369	CbGpPWpGaD
Levosimendan—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	5.36e-05	0.018	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—RAC1—dilated cardiomyopathy	5.36e-05	0.000367	CbGpPWpGaD
Levosimendan—Constipation—Lisinopril—dilated cardiomyopathy	5.31e-05	0.0178	CcSEcCtD
Levosimendan—Vomiting—Furosemide—dilated cardiomyopathy	5.26e-05	0.0176	CcSEcCtD
Levosimendan—Headache—Furosemide—dilated cardiomyopathy	5.19e-05	0.0174	CcSEcCtD
Levosimendan—KCNJ11—Neuronal System—RAF1—dilated cardiomyopathy	5.07e-05	0.000348	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.05e-05	0.000346	CbGpPWpGaD
Levosimendan—Nausea—Furosemide—dilated cardiomyopathy	4.92e-05	0.0165	CcSEcCtD
Levosimendan—PDE3A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	4.89e-05	0.000335	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.6e-05	0.000315	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.36e-05	0.000299	CbGpPWpGaD
Levosimendan—Diarrhoea—Lisinopril—dilated cardiomyopathy	4.25e-05	0.0142	CcSEcCtD
Levosimendan—PDE3A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.18e-05	0.000286	CbGpPWpGaD
Levosimendan—Dizziness—Lisinopril—dilated cardiomyopathy	4.11e-05	0.0138	CcSEcCtD
Levosimendan—PDE3A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.96e-05	0.000272	CbGpPWpGaD
Levosimendan—Vomiting—Lisinopril—dilated cardiomyopathy	3.95e-05	0.0132	CcSEcCtD
Levosimendan—Headache—Lisinopril—dilated cardiomyopathy	3.89e-05	0.013	CcSEcCtD
Levosimendan—Nausea—Lisinopril—dilated cardiomyopathy	3.69e-05	0.0124	CcSEcCtD
Levosimendan—PDE3A—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.61e-05	0.000248	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—RAF1—dilated cardiomyopathy	3.55e-05	0.000244	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.39e-05	0.000232	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.24e-05	0.000222	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.21e-05	0.00022	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.21e-05	0.00022	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.08e-05	0.000211	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.98e-05	0.000204	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AGT—dilated cardiomyopathy	2.94e-05	0.000201	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.89e-05	0.000198	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.47e-05	0.000169	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.34e-05	0.00016	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GPX1—dilated cardiomyopathy	2.1e-05	0.000144	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CD36—dilated cardiomyopathy	2.04e-05	0.00014	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.04e-05	0.00014	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.01e-05	0.000138	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AGT—dilated cardiomyopathy	1.84e-05	0.000126	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.82e-05	0.000125	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AGT—dilated cardiomyopathy	1.74e-05	0.000119	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.4e-05	9.59e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.2e-05	8.26e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EGFR—dilated cardiomyopathy	8.26e-06	5.66e-05	CbGpPWpGaD
